Xavier Palard
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Predictive value of [99mTc]Tc-MAA SPECT/CT personalised dosimetry in 90Y radioembolization of hepatocellular carcinoma: a DOSISPHERE-01 ancillary study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 14, 2026
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
Journal: Immuno-oncology technology
Published: January 08, 2026
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
Journal: Immuno-oncology technology
Published: January 08, 2026
Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel.
Journal: HemaSphere
Published: April 01, 2024
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 22, 2023
188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study).
Journal: Cancers
Published: February 20, 2023
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
Journal: Scientific reports
Published: December 08, 2021
Trans-arterial Radioembolization Dosimetry in 2022.
Journal: Cardiovascular and interventional radiology
Published: November 03, 2021
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.
Journal: European journal of gastroenterology & hepatology
Published: July 20, 2021
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma.
Journal: Cancers
Published: July 15, 2021
18F-FDG PET/CT-Based Prognostic Survival Model After Surgery for Head and Neck Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 11, 2021
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: June 23, 2020
Last Updated: 09/26/2026